Powered by

Seres Therapeutics Strengthens Board of Directors with Appointment of Meryl Zausner, Experienced Biopharmaceutical Financial Leader

Sep 04, 2018 - Business Wire
Board and Executive Moves

Seres Therapeutics, Inc . (Nasdaq:MCRB) today announced the appointment of Meryl Zausner, a seasoned biopharmaceutical executive, to its Board of Directors. Ms. Zausner brings decades of financial and operational leadership experience in the pharmaceutical industry.

"Meryl Zausner is a highly accomplished financial and strategic leader, and I am delighted to welcome her to the Seres Board," said Roger J. Pomerantz, M.D., President, CEO and Chairman of Seres. "Meryl's extensive biopharmaceu...